Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination
E Derhovanessian, H Theeten, K Hähnel… - Vaccine, 2013 - Elsevier
Influenza vaccination is less effective in the elderly compared to the young. Studies that have
attempted to identify immune parameters correlating with satisfactory vaccine responses …
attempted to identify immune parameters correlating with satisfactory vaccine responses …
[HTML][HTML] Seroprevalence of IgG antibodies against SARS-CoV-2–a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October …
…, P Van Damme, N Hens, H Theeten - …, 2022 - eurosurveillance.org
Background To control epidemic waves, it is important to know the susceptibility to SARS-CoV-2
and its evolution over time in relation to the control measures taken. Aim To assess the …
and its evolution over time in relation to the control measures taken. Aim To assess the …
[HTML][HTML] COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020
Background COVID-19 mortality, excess mortality, deaths per million population (DPM),
infection fatality ratio (IFR) and case fatality ratio (CFR) are reported and compared for many …
infection fatality ratio (IFR) and case fatality ratio (CFR) are reported and compared for many …
[HTML][HTML] Long-term antibody persistence after vaccination with a 2-dose Havrix™(inactivated hepatitis A vaccine): 20 years of observed data, and long-term model …
H Theeten, K Van Herck, O Van Der Meeren, P Crasta… - Vaccine, 2015 - Elsevier
Antibody persistence in two cohorts of adults, who received inactivated hepatitis A (HAV)
vaccine (1440El.U; Havrix™; GSK Vaccines) according to a 0–6 or 0–12 month schedule in …
vaccine (1440El.U; Havrix™; GSK Vaccines) according to a 0–6 or 0–12 month schedule in …
Timeliness of infant vaccination and factors related with delay in Flanders, Belgium
T Lernout, H Theeten, N Hens, T Braeckman… - Vaccine, 2014 - Elsevier
Achieving high vaccination coverage is a necessary, but not a sufficient indicator of the
quality of a vaccination programme, in terms of control and prevention of childhood infectious …
quality of a vaccination programme, in terms of control and prevention of childhood infectious …
[HTML][HTML] Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures
L Willen, E Ekinci, L Cuypers, H Theeten… - Frontiers in Cellular …, 2022 - frontiersin.org
Streptococcus pneumoniae is an important and frequently carried respiratory pathogen that
has the potential to cause serious invasive diseases, such as pneumonia, meningitis, and …
has the potential to cause serious invasive diseases, such as pneumonia, meningitis, and …
[PDF][PDF] Towards elimination: measles susceptibility in Australia and 17 European countries
…, K Prosenc, M Slácˇiková, H Theeten… - Bulletin of the World …, 2008 - SciELO Public Health
OBJECTIVE: To evaluate age-specific measles susceptibility in Australia and 17 European
countries. METHODS: As part of the European Sero-Epidemiology Network 2 (ESEN2), 18 …
countries. METHODS: As part of the European Sero-Epidemiology Network 2 (ESEN2), 18 …
[PDF][PDF] Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets
…, N Andrews, J Backhouse, H Theeten… - Bulletin of the World …, 2008 - SciELO Public Health
OBJECTIVE: To standardize serological surveillance to compare rubella susceptibility in
Australia and 16 European countries, and measure progress towards international disease-…
Australia and 16 European countries, and measure progress towards international disease-…
Belgian covid-19 mortality, excess deaths, number of deaths per million, and infection fatality rates (8 March-9 May 2020)
Objective Scrutiny of COVID-19 mortality in Belgium over the period 8 March – 9 May 2020 (Weeks
11-19), using number of deaths per million, infection fatality rates, and the relation …
11-19), using number of deaths per million, infection fatality rates, and the relation …
Vaccination coverage and sociodemographic determinants of measles–mumps–rubella vaccination in three different age groups
C Vandermeulen, M Roelants, H Theeten… - European Journal of …, 2008 - Springer
WHO–Europe’s goal is to eliminate measles and rubella by 2010 which will require a coverage
rate of 95% for both MMR-vaccine doses. Belgian recommendations include a first MMR …
rate of 95% for both MMR-vaccine doses. Belgian recommendations include a first MMR …